Natera, Inc. NTRA
289.50 USD +2.03 (+0.71%)
Regular-session close
289.50 0.00 0.00%
After hours · Nov 18, 4:00 PM ET
277.50 Day range 289.59
181.00 52-week range 437.41
- YTD
- +26.37%
- 1 year
- +35.50%
News
benzinga.com BillionToOne Faces Short Report Alleging Kickbacks, Flawed Diagnostic Tests Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
fool.com Billionaire Stanley Druckenmiller Says He's 'Staying Away' From Stocks. Here's What He Bought and Sold Last Quarter The billionaire investor says he's focused on not losing money right now. His newest SEC filing shows how much he had already reshaped his portfolio by the end of September.
benzinga.com SpaceX Stock Lands in Stanley Druckenmiller’s Duquesne Portfolio Druckenmiller’s Duquesne bought a $30M SpaceX stake, halved Tesla call exposure, boosted Amazon and exited Alphabet in Q3.
benzinga.com Natera Short Interest Rises As Bets Remain Near September Peak Natera Inc. (NASDAQ:NTRA) short sellers added to their positions as of the latest settlement date.Short interest rose 3.77% to 6.07 million shares as of the Oct. 30 settlement date, from 5.85 million…
businesswire.com HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening & Early Detection AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named the Best in Class winner in the Cancer,…
defenseworld.net Natera CFO Defends CEO Switch, Calls $6 Billion Revenue Target a “Way Station” Natera (NASDAQ: NTRA) CFO Mike Brophy said the company's newly announced $6 billion revenue target for 2029 is achievable with strong execution, as he outlined expectations for its Signatera cancer…
defenseworld.net Natera, Inc. $NTRA Stock Sold by Eurizon Capital SGR S.p.A. Eurizon Capital SGR S.p.A. trimmed its position in Natera, Inc. (NASDAQ: NTRA) by 16.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and…
marketbeat.com Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029 Natera NASDAQ: NTRA Chief Financial Officer Mike Brophy said the company has multiple paths to its $6 billion revenue target for 2029, citing growth in its Signatera cancer testing business and…
marketbeat.com Natera CFO Defends CEO Switch, Calls $6 Billion Revenue Target a “Way Station” Natera NASDAQ: NTRA CFO Mike Brophy said the company's newly announced $6 billion revenue target for 2029 is achievable with strong execution, as he outlined expectations for its Signatera cancer…
benzinga.com Micron, Moody’s, Digital Realty and a Health Care Stock on CNBC’s ‘Final Trades’ CNBC traders picked Micron, Digital Realty, Natera and Moody’s; Natera raised FY2026 sales guidance after strong results, while Moody’s missed estimates.
seekingalpha.com Natera, Inc. (NTRA) Presents at 2026 UBS Global Healthcare Conference Transcript Natera, Inc. ( NTRA ) 2026 UBS Global Healthcare Conference November 9, 2026 8:00 AM EST Company Participants Mike Brophy - Chief Financial Officer Conference Call Participants Douglas Schenkel - UBS…
seekingalpha.com Natera, Inc. (NTRA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript Natera, Inc. ( NTRA ) 8th Annual Wolfe Research Healthcare Conference November 10, 2026 12:00 PM EST Company Participants Mike Brophy - Chief Financial Officer Conference Call Participants Paige…benzinga.com Natera Enters Into Clinical Collaboration Agreement With Incyte For New Phase II Study In Colorectal Cancer Trial designed to improve outcomes through Signatera™-guided Treatment on MRD (TOMR), identifying high-risk patients for curative-intent treatmentNatera, Inc. (NASDAQ:NTRA), a global leader in…
benzinga.com Baird Maintains Outperform on Natera, Lowers Price Target to $403 Baird analyst Catherine Ramsey maintains Natera (NASDAQ:NTRA) with a Outperform and lowers the price target from $458 to $403.
benzinga.com JP Morgan Maintains Overweight on Natera, Lowers Price Target to $405 JP Morgan analyst Casey Woodring maintains Natera (NASDAQ:NTRA) with a Overweight and lowers the price target from $460 to $405.
benzinga.com Natera Stock Plummets After Mixed Q3 Financials Natera shares are plunging Friday after mixed Q3 results, as a wider-than-expected loss offset revenue and guidance that topped estimates.
benzinga.com If You Invested $100 In Natera Stock 10 Years Ago, You Would Have This Much Today Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 27.7% on an annualized basis producing an average annual return of 40.73%. Currently, Natera has a market capitalization of…benzinga.com Evercore ISI Group Maintains Outperform on Natera, Lowers Price Target to $400 Evercore ISI Group analyst Daniel Markowitz maintains Natera (NASDAQ:NTRA) with a Outperform and lowers the price target from $468 to $400.
benzinga.com DraftKings Posts Downbeat Q3 Results, Joins Atlassian, Natera And Other Big Stocks Moving Lower In Friday’s Pre-Market Session Stock futures mixed as DraftKings plunged 21% after earnings missed estimates and FY26 guidance was cut; several other stocks also fell premarket.
benzinga.com Natera Q3 2026 Earnings Call Transcript Natera (NASDAQ:NTRA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time access…benzinga.com Natera Q3 EPS $(0.42) Misses $(0.29) Estimate, Sales $793.981M Beat $704.901M Estimate Natera (NASDAQ:NTRA) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 34.38 percent increase over losses of $(0.64)…
benzinga.com Natera Raises FY2026 Sales Guidance from $2.850B-$2.910B to $3.005B-$3.035B vs $2.907B Est Natera (NASDAQ:NTRA) raises FY2026 sales outlook from $2.850 billion-$2.910 billion to $3.005 billion-$3.035 billion vs $2.907 billion estimate.
benzinga.com Toyota, ConocoPhillips On Deck Thursday As Auto Demand, Oil Prices Face Test Toyota Motor headlines Thursday’s reports, with investors weighing the automaker’s earnings outlook against a stock still well below its 52-week high. ConocoPhillips, Sony Group, Parker Hannifin and…
benzinga.com Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.
benzinga.com Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet The Stock Whisper Index is a market indicator highlighting stocks that are attracting heightened interest from traders and investors over the last trading week.
benzinga.com Natera, Shake Shack, eBay And More On CNBC’s ‘Final Trades’ CNBC Final Trades: Sechan picked eBay, Simpson Natera, Thomas COWZ ETF and Brown Shake Shack; all four gained Thursday.benzinga.com BTIG Maintains Buy on Natera, Raises Price Target to $430 BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $320 to $430.
benzinga.com Natera Highlights New Signatera Genome Assay Data At ESMO 2026, With ctDNA Dynamics Predictive Of Survival Outcomes In Bladder Cancer Natera’s oncology portfolio featured in 25 ESMO abstracts including 9 oral presentations, with publications in Nature Medicine and ESMO OpenNatera, Inc. (NASDAQ:NTRA), a global leader in cell-free…
benzinga.com $100 Invested In Natera 5 Years Ago Would Be Worth This Much Today Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 17.81% on an annualized basis producing an average annual return of 28.94%. Currently, Natera has a market capitalization of…benzinga.com Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $500 Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $375 to $500.
